Abstract
PROSTAGLANDINSand glucocorticoids are potent mediators of inflammation. Non-steroidal anti-inflammatory drugs (NSAIDs) exert their effects by inhibition of prostaglandin production. The pharmacological target of NSAIDs is cyclooxygenase (COX, also known as PGH synthase), which catalyses the first committed step in arachidonic-acid metabolism1,2. Two isoforms of the membrane protein COX are known3: COX-1, which is constitu-tively expressed in most tissues, is responsible for the physiological production of prostaglandins4; and COX-2, which is induced by cytokines, mitogens and endotoxins in inflammatory cells5, is responsible for the elevated production of prostaglandins during inflammation6,7. The structure of ovine COX-1 complexed with several NSAIDs has been determined8–10. Here we report the structures of unliganded murine COX-2 and complexes with flurbiprofen, indomethacin and SC-558, a selective COX-2 inhibitor, determined at 3.0 to 2.5 Åresolution. These structures explain the structural basis for the selective inhibition of COX-2, and demonstrate some of the conformational changes associated with time-dependent inhibition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Smith, W. L. & Marnett, L. J. in Metal Ions in Biological Systems (eds Sigel, H. & Sigel, A.) 163–199 (Marcel Dekker, New York, 1994).
Otto, J. C. & Smith, W. L. J. Lipid Mediat. Cell Signal. 12, 139–156 (1995).
Vane, J. R. et al. Proc. Natl Acad. Sci. USA 91, 2046–2050 (1994).
DeWitt, D. L. et al. J. Biol. Chem. 265, 5192–5196 (1990).
Herschman, H. R. Biochim. Biophys. Acta 1299, 125–140 (1996).
Seibert, K. et al. Proc. Natl Acad. Sci. USA 91, 12013–12017 (1994).
Masferrer, J. L. et al. Proc. Natl Acad. Sci. USA 91, 3228–3232 (1994).
Picot, D., Loll, P. J. & Garavito, R. M. Nature 367, 243–249 (1994).
Loll, P. J., Picot, D. & Garavito, R. M. Nature Struct. Biol. 2, 637–643 (1995).
Loll, P. J., Picot, D., Ekabo, O. & Garavito, R. M. Biochemistry 35, 7330–7340 (1996).
Marnett, L. J. & Maddipati, K. R. in Peroxidasesin Chemistry and Biology Vol 1 (eds Everse, K. E. & Grisham, M. B.) 293–334 (CRC Press, Boca Raton, FL, 1991).
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J. & Vane, J. R. Proc. Natl Acad. Sci. USA 90, 11693–11697 (1993).
Laneuville, O. et al. J. Pharmacol. Exp. Ther. 271, 927–934 (1994).
Gans, K. R. et al. J. Pharmacol. Exp. Ther. 254, 180–187 (1990).
Futaki, N. et al. Prostaglandins 47, 55–59 (1994).
Smith, W. L., Eling, T. E., Kulmacz, R. J., Marnett, L. J. & Tsai, A. Biochemistry 31, 3–7 (1992).
Dietz, R., Nastainczyk, W. & Ruf, H. H. Eur. J. Biochem. 171, 320–327 (1988).
Van, J. R. Nature New. Biol. 231, 232–235 (1971).
Hoogsteen, K. & Trenner, N. R. J. Org. Chem. 35, 521 (1970).
Black, W. C. et al. Bioorg. Med. Chem. Lett. 6, 725–730 (1996).
Gierse, J. K. et al. J. Biol. Chem. 271, 15810–15814 (1996).
Bertenshaw, S. R. et al. Bioorg. Med. Chem. Lett. 5, 2919–2922 (1995).
Kulmacz, R. J. & Lands, W. E. M. J. Biol. Chem. 260, 12572–12578 (1985).
Bhattacharyya, D. K., Lecomte, M., Rieke, C. J., Garavito, R. M. & Smith, W. L. J. Biol. Chem. 271, 2179–2184 (1996).
Copeland, R. A. et al. Proc. Natl Acad. Sci. USA 91, 11202–11206 (1994).
Gierse, J. K. et al. Biochem. J. 305, 479–484 (1995).
Otwinowski, Z. & Minor, W. in Data Collection and Processing (eds Sawyer, L., Isaacs, N. & Bailey, S.) 556–562 (SERC Daresbury Laboratory, Warrington, UK, 1993).
Fitzgerald, P. M. D. J. Appl. Crystallogr. 21, 273–278 (1988).
Brunger, A. T. XPLOR (Version 3.1): A System for X-ray Crystallography and NMR (Yale Univ. Press, New Haven, CT, 1993).
Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgarrd, M. Acta Crystallogr. A47, 110–119 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kurumbail, R., Stevens, A., Gierse, J. et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384, 644–648 (1996). https://doi.org/10.1038/384644a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/384644a0
This article is cited by
-
Crystal structure, DFT studies, in silico evaluation of as a potential inhibitor against monkeypox virus, and ADMET properties of tetrachlorometallate salts of procaine
Chemical Papers (2024)
-
A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases
Scientific Reports (2023)
-
Comparative structural study of selective and non-selective NSAIDs against the enzyme cyclooxygenase-2 through real-time molecular dynamics linked to post-dynamics MM-GBSA and e-pharmacophores mapping
Journal of Molecular Modeling (2023)
-
Novel Benzo[4,5]imidazo[1,2-a]pyrimidine derivatives as selective Cyclooxygenase-2 Inhibitors: Design, synthesis, docking studies, and biological evaluation
Medicinal Chemistry Research (2023)
-
Design, synthesis, and biological evaluation of dual-target COX-2/5-LOX inhibitors for the treatment of inflammation
Medicinal Chemistry Research (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.